id,jsonhtml
"Abnormal glucose metabolism","{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Metabolism and nutrition disorders"",""section"":""Glucose intolerance""}],""rubric"":[""Asymptomatic; clinical or diagnostic observations only; pharmacologic intervention not indicated or initiated (e.g. dietary modification)"",""Symptomatic; oral agent indicated or initiated"",""Severe symptoms; insulin indicated or initiated"",""Life threatening consequences, urgent intervention indicated or initiated"",""Death""]}"
Amputation,"{""src"":[{""section"":""ICD-9-CM Diagnosis and Procedure Codes:"",""title"":""Abbreviated and Full Code Titles."",""pub"":""Centers for Medicare & Medicaid Services""}],""rubric"":[""Partial ostectomy or other bone repair"",""Amputation below ankle or below elbow; revision of amputation"",""Total ostectomy; upper extremity amputation above elbow or higher; lower extremity amputation above ankle or higher"",""Not applicable"",""Not applicable""]}"
"Atrioventricular heart block","{""src"":[{""pub"":""CTCAE v4.03"",""title"":""Cardiac Disorders"",""section"":""AV Block first degree (grades 1&2); AV block complete; Mobitz (type) II AV block; Mobitz type I (grades 3&4)""}],""rubric"":[""Asymptomatic; intervention not indicated"",""Symptomatic; non-urgent medical intervention indicated"",""Symptomatic and incompletely controlled medically, or controlled with device (e.g., pacemaker)"",""Life-threatening consequences; urgent intervention indicated"",""Death""]}"
"Conduction abnormalities","{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Cardiac Disorders"",""section"":""Conduction disorder""}],""rubric"":[""Asymptomatic or mild symptoms; intervention not indicated"",""Moderate symptoms; non-urgent intervention indicated"",""Severe symptoms; intervention indicated"",""Life-threatening consequences; urgent intervention indicated"",""Death""]}"
"Prolonged QT interval","{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Investigations"",""section"":""Prolonged QTc interval""}],""rubric"":[""QTc 460 - 480 ms (men); 470-480 ms (women)"",""QTc 481 - 500 ms"",""QTc >= 501 ms on >= two separate ECGs"",""QTc >= 501 or >60 ms change from baseline and Torsade de pointes or polymorphic ventricular tachycardia or signs/symptoms of serious arrhythmia"",""Not applicable""]}"
"Cardiac dysrhythmia","{""src"":[{""pub"":""CTCAE v4.03"",""title"":""Cardiac Disorders"",""section"":""Atrial fibrillation""}],""rubric"":[""Asymptomatic, intervention not indicated"",""Non-urgent medical intervention indicated"",""Symptomatic and incompletely controlled medically, or controlled with device (e.g., pacemaker), or ablation"",""Life-threatening consequences; urgent intervention indicated"",""Death""]}"
"Right ventricular systolic dysfunction","{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Cardiac Disorders"",""section"":""Right ventricular dysfunction""}],""rubric"":[""Asymptomatic cardiac imaging abnormalities"",""Symptoms with mild to moderate activity or exertion"",""Severe symptoms, associated with hypoxia, right heart failure; oxygen indicated"",""Life-threatening consequences; urgent intervention indicated (e.g., ventricular assist device); heart transplant indicated"",""Death""]}"
"Cor pulmonale (right heart failure)","{""src"":[{""pub"":""CTCAE v4.03"",""title"":""Cardiac Disorders"",""section"":""Right ventricular dysfunction""}],""rubric"":[""Asymptomatic with laboratory (e.g., BNP) or cardiac imaging abnormalities"",""Symptoms with mild to moderate activity or exertion"",""Severe symptoms, associated with hypoxia, right heart failure; oxygen indicated"",""Life-threatening consequences; urgent intervention indicated (e.g., ventricular assist device); heart transplant indicated"",""Death""]}"
"Pulmonary hypertension","{""src"":[{""pub"":""CTCAE v4.03"",""title"":""Respiratory, thoracic, and mediastinal disorders"",""section"":""Pulmonary hypertension""}],""rubric"":[""Minimal dyspnea; findings on physical exam or other evaluation"",""Moderate dyspnea, cough; requiring evaluation by cardiac catheterization and medical intervention"",""Severe symptoms, associated with hypoxemia, right heart failure; oxygen indicated"",""Life-threatening airway consequences; urgent intervention indicated (e.g., tracheotomy or intubation)"",""Death""]}"
"Genitourinary adhesions","{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Reproductive system and breast disorders"",""section"":""Other, specify""}],""rubric"":[""Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated"",""Moderate; minimal, local or noninvasive intervention indicated; limiting age appropriate instrumental ADL"",""Severe or medically significant but not immediately life threatening; hospitalization or prolongation of existing hospitalization indicated; disabling; limiting self-care ADL"",""Life-threatening consequences; urgent intervention indicated"",""Death""]}"
"Cervical dysplasia","{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Reproductive system and breast disorders"",""section"":""Other, specify""}],""rubric"":[""Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated"",""Moderate; minimal, local or non-invasive intervention indicated; limiting age appropriate instrumental ADL (e.g., colposcopy)"",""Severe or medically significant but not immediately life threatening; hospitalization or prolongation of existing hospitalization indicated; disabling; limiting self-care ADL (e.g., conization for carcinoma-in-situ)"",""Not applicable"",""Not applicable""]}"
Endometriosis,"{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Reproductive system and breast disorders"",""section"":""Other, specify""}],""rubric"":[""Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated"",""Moderate; minimal, local or noninvasive intervention indicated; limiting age appropriate instrumental ADL (e.g., medical management)"",""Severe or medically significant but not immediately life threatening; hospitalization or prolongation of existing hospitalization indicated; disabling; limiting self-care ADL (e.g., surgical intervention)"",""Life-threatening consequences; urgent intervention indicated"",""Death""]}"
"Dysfunctional uterine bleeding","{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Reproductive system and breast disorders"",""section"":""Menorrhagia""}],""rubric"":[""Mild; iron supplements indicated"",""Moderate symptoms; medical intervention indicated (e.g., hormones)"",""Severe; transfusion indicated; surgical intervention indicated (e.g., hysterectomy)"",""Life-threatening consequences; urgent intervention indicated"",""Death""]}"
Dyspareunia,"{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Reproductive system and breast disorders"",""section"":""Dyspareunia""}],""rubric"":[""Mild discomfort or pain associated with vaginal penetration; discomfort relieved with use of vaginal lubricants or estrogen"",""Moderate discomfort or pain associated with vaginal penetration; discomfort or pain partially relieved with use of vaginal lubricants or estrogen"",""Severe discomfort or pain associated with vaginal penetration; discomfort or pain unrelieved by vaginal lubricants or estrogen"",""Not applicable"",""Not applicable""]}"
"Polycystic ovarian syndrome","{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Reproductive system and breast disorders"",""section"":""Other, specify""}],""rubric"":[""Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated (e.g., mild signs/symptoms of hyperandrogenemia)"",""Moderate; minimal, local or noninvasive intervention indicated; limiting age appropriate instrumental ADL (e.g., more severe hirsutism, irregular menses; need for metformin or hormone replacement)"",""Severe or medically significant but not immediately life threatening; hospitalization or prolongation of existing hospitalization indicated; disabling; limiting self-care ADL (e.g., need for surgery for cyst or bleed)"",""Not applicable"",""Not applicable""]}"
"Vaginal fistula","{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Reproductive system and breast disorders"",""section"":""Female genital tract fistula""}],""rubric"":[""Asymptomatic clinical or diagnostic observations only; intervention not indicated"",""Symptomatic and intervention not indicated"",""Severe symptoms; elective operative intervention indicated"",""Life-threatening consequences; urgent intervention indicated"",""Death""]}"
"Vaginal stenosis","{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Reproductive system and breast disorders"",""section"":""Vaginal stricture""}],""rubric"":[""Asymptomatic; mild vaginal shortening or narrowing"",""Vaginal narrowing and/or shortening not interfering with physical examination"",""Vaginal narrowing and/or shortening interfering with the use of tampons, sexual activity or physical examination (e.g., surgical intervention indicated or performed)"",""Not applicable"",""Not applicable""]}"
"Erectile dysfunction","{""src"":[{""pub"":""CTCAE v4.03"",""title"":""Reproductive system and breast disorders"",""section"":""Erectile dysfunction""}],""rubric"":[""Decrease in erectile function (frequency or rigidity of erections) but intervention not indicated (e.g., medication or use of mechanical device, penile pump)"",""Decrease in erectile function (frequency/ rigidity of erections), erectile intervention indicated, (e.g., medication or mechanical devices such as penile pump)"",""Decrease in erectile function (frequency/ rigidity of erections) but erectile intervention not helpful (e.g., medication or mechanical devices such as penile pump); placement of a permanent penile prosthesis indicated (not previously present)"",""Not applicable"",""Not applicable""]}"
"Retrograde ejaculation","{""src"":[{""pub"":""CTCAE v4.03"",""title"":""Reproductive system and breast disorders"",""section"":""Ejaculation disorder""}],""rubric"":[""Diminished ejaculation"",""Anejaculation or retrograde ejaculation"",""Not applicable"",""Not applicable"",""Not applicable""]}"
"Prostatic hypertrophy, benign","{""src"":[{""pub"":""CTCAE v4.03"",""title"":""Reproductive system and breast disorders"",""section"":""Prostatic obstruction""}],""rubric"":[""Diagnostic observations only; intervention not indicated"",""Mild symptoms; elective intervention indicated"",""Severe symptoms; elective operative intervention indicated"",""Not applicable"",""Not applicable""]}"
Cholecystitis,"{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Hepatobiliary disorders"",""section"":""Cholecystitis""}],""rubric"":[""Not applicable"",""Symptomatic; medical intervention indicated"",""Severe symptoms; invasive intervention indicated (e.g radiologic, endoscopic or elective operative intervention)"",""Life-threatening consequences; urgent operative intervention indicated"",""Death""]}"
Dysphagia,"{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Gastrointestinal disorders"",""section"":""Dysphagia""}],""rubric"":[""Symptomatic, able to eat regular diet"",""Symptomatic and altered eating or swallowing"",""Severely altered eating or swallowing; tube feeding or TPN or hospitalization indicated"",""Life-threatening consequences; urgent intervention indicated"",""Death""]}"
"Esophageal varices","{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Gastrointestinal disorders"",""section"":""Esophageal varices""}],""rubric"":[""Not applicable"",""Self-limited; intervention not indicated"",""Transfusion, radiologic, endoscopic, or elective operative intervention indicated"",""Life-threatening consequences; urgent intervention indicated"",""Death""]}"
Esophagitis,"{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Gastrointestinal disorders"",""section"":""Esophagitis""}],""rubric"":[""Asymptomatic; clinical or diagnostic observations only; intervention not indicated"",""Symptomatic; altered eating/swallowing; oral supplements indicated"",""Severely altered eating/swallowing; tube feeding, TPN or hospitalization indicated"",""Life-threatening consequences; urgent operative intervention indicated"",""Death""]}"
"Chronic obstructive pulmonary disease","{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Respiratory, thoracic and mediastinal disorders"",""section"":""Other, specify""}],""rubric"":[""Mild symptoms; intervention not Indicated"",""Symptomatic; medical intervention indicated; limiting instrumental ADL; intermittent asthma requiring short-acting beta agonists as needed"",""Limiting self-care ADL; oxygen saturation decreased; persistent asthma requiring daily controller medication (oral or inhaled)"",""Life-threatening respiratory or hemodynamic compromise; intubation or urgent intervention indicated"",""Death""]}"
"Restrictive pulmonary deficit","{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Respiratory, thoracic and mediastinal disorders"",""section"":""Bronchospasm""}],""rubric"":[""Mild symptoms; intervention not Indicated"",""Symptomatic; medical intervention indicated; limiting instrumental ADL; intermittent asthma requiring short-acting beta agonists as needed"",""Limiting self-care ADL; oxygen saturation decreased; persistent asthma requiring daily controller medication (oral or inhaled)"",""Life-threatening respiratory or hemodynamic compromise; intubation or urgent intervention indicated"",""Death""]}"
"Pulmonary diffusion deficit","{""src"":[{""pub"":""Eur Resp J "",""title"":""Interpretative strategies for lung function tests"",""section"":""2005;26:948-968. Table 14""}],""rubric"":[""DLCO: 74-60% predicted"",""DLCO: <60%-40% predicted"",""DLCO: <40% predicted"",""Not applicable"",""Not applicable""]}"
"Portal hypertension","{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Gastrointestinal disorders"",""section"":""Portal hypertension""}],""rubric"":[""Not applicable"",""Decreased portal vein flow"",""Reversal/retrograde portal vein flow; associated with varices and/or ascites"",""Life-threatening consequences; urgent intervention indicated"",""Death""]}"
"Hepatic failure","{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Gastrointestinal disorders"",""section"":""Hepatic failure""}],""rubric"":[""Not applicable"",""Not applicable"",""Asterixis; mild encephalopathy; limiting self-care ADL"",""Moderate to severe encephalopathy; coma; life threatening consequences; requiring liver transplantation"",""Death""]}"
Hepatopathy,"{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Investigations"",""section"":""Alanine and aspartate aminotransferase Increased""}],""rubric"":["">ULN - 3.0 x ULN"","">3.0 - 5.0 x ULN"","">5.0 - 20.0 x ULN"","">20.0 x ULN"",""Not applicable""]}"
"Veno-occlusive disease of liver","{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Hepatobiliary disorders"",""section"":""Other, specify""}],""rubric"":[""Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated"",""Moderate; minimal, local or noninvasive intervention indicated; limiting age appropriate instrumental ADL"",""Severe or medically significant but not immediately life threatening; hospitalization or prolongation of existing hospitalization indicated; disabling; limiting self-care ADL"",""Life-threatening consequences; urgent intervention indicated"",""Death""]}"
Glaucoma,"{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Eye disorders"",""section"":""Glaucoma""}],""rubric"":[""Elevated intraocular pressure (EIOP) with single topical agent for intervention; no visual field deficit"",""EIOP causing early visual field deficits; multiple topical or oral agents indicated; limiting instrumental ADL"",""EIOP causing marked visual field deficits (e.g., involving both superior and inferior visual fields); operative intervention indicated; limiting self- care ADL"",""Blindness (20/200 or worse) in the affected eye"",""Not applicable""]}"
Hypertriglyceridemia,"{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Metabolism and Nutrition Disorders"",""section"":""Hypertriglyceridemia""}],""rubric"":[""150 mg/dL - 300 mg/dL"","">300 mg/dL - 500 mg/dL; treatment with one lipid lowering agent"","">500 mg/dL - 1000 mg/dL; treatment with >=2 lipid lowering agents"","">1000 mg/dL; life-threatening consequences"",""Death""]}"
Hypercholesterolemia,"{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Investigations"",""section"":""Cholesterol high""}],""rubric"":["">200 mg/dL - 300 mg/dL"","">300 - 400 mg/dL; treatment with one lipid lowering agent"","">400 - 500 mg/dL; treatment with >=2 lipid lowering agent"","">500 mg/dL"",""Not applicable""]}"
Hypertension,"{""src"":[{""pub"":""CTCAE v4.03"",""title"":""Vascular Disorders"",""section"":""Hypertension""},{""pub"":""Pediatrics"",""title"":""National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents."",""section"":""2004;114(2 Suppl 4th Report):555.""}],""rubric"":[""Prehypertension (systolic BP 120 - 139 mm Hg or diastolic BP 80 - 89 mm Hg)"",""Stage 1 hypertension (systolic BP 140 - 159 mm Hg or diastolic BP 90 - 99 mm Hg); medical intervention indicated or initiated; recurrent or persistent (>=24 hrs); symptomatic increase by >20 mm Hg (diastolic) or to >140/90 mm Hg if previously WNL; monotherapy indicated or initiated"",""Stage 2 hypertension (systolic BP >=160 mm Hg or diastolic BP >=100 mm Hg); medical intervention indicated; more than one drug or more intensive therapy than previously used indicated or initiated"",""Life-threatening consequences (e.g., malignant hypertension, transient or permanent neurologic deficit, hypertensive crisis); urgent intervention indicated"",""Death"",""Prehypertension (systolic and/or diastolic BP >= 90th percentile but < 95th percentile for gender, age and height, or if in adolescents BP exceeds 120/80 mmHg even if <90th percentile)"",""Stage 1 hypertension (systolic and/or diastolic BP between the 95th percentile and 5 mmHg above the 99th percentile for gender, age and height, or if in adolescents the BP exceeds 140/90 mmHg even <95th percentile); monotherapy indicated or initiated"",""Stage 2 hypertension (systolic and/or diastolic BP ≥99th percentile plus 5 mmHg for gender, age, and height); more than one drug or more intensive therapy than previously used indicated or initiated"",""Life-threatening consequences (e.g., malignant hypertension, transient or permanent neurologic deficit, hypertensive crisis); urgent intervention indicated"",""Death""]}"
"Peripheral sensory neuropathy","{""src"":[{""pub"":""CTCAE v4.03"",""title"":""Vascular Disorders"",""section"":""Peripheral sensory neuropathy""}],""rubric"":[""Asymptomatic; loss of deep tendon reflexes or paresthesia"",""Moderate symptoms; limiting instrumental ADL"",""Severe symptoms; limiting self-care ADL"",""Life-threatening consequences; urgent intervention indicated"",""Death""]}"
"Peripheral motor neuropathy","{""src"":[{""pub"":""CTCAE v4.03"",""title"":""Vascular Disorders"",""section"":""Peripheral motor neuropathy""}],""rubric"":[""Asymptomatic; clinical or diagnostic observations only; intervention not indicated"",""Moderate symptoms; limiting instrumental ADL"",""Severe symptoms; limiting self- care ADL; assistive device indicated"",""Life-threatening consequences; urgent intervention indicated"",""Death""]}"
"Urinary bladder dysfunction","{""src"":[{""pub"":""CTCAE v4.03"",""title"":""Renal and urinary disorders"",""section"":""Urinary frequency; Urinary urgency""}],""rubric"":[""Present"",""Limiting instrumental ADL; medical management indicated or initiated"",""Surgical management indicated or initiated (e.g., trans-electrical nerve stimulation, sacral neural modulation)"",""Not applicable"",""Not applicable""]}"
"Urinary Incontinence","{""src"":[{""pub"":""CTCAE v4.03"",""title"":""Renal and urinary disorders"",""section"":""Urinary incontinence""}],""rubric"":[""Occasional (e.g., with coughing, sneezing, etc.), pads not indicated"",""Spontaneous; pads indicated; limiting instrumental ADL"",""Intervention indicated (e.g., clamp, collagen injections); operative intervention indicated; limiting self-care ADL"",""Not applicable"",""Not applicable""]}"
"Chronic hematuria","{""src"":[{""pub"":""CTCAE v4.03"",""title"":""Renal and urinary disorders"",""section"":""Hematuria""}],""rubric"":[""Asymptomatic; clinical or diagnostic observations only; intervention not indicated"",""Symptomatic; urinary catheter or bladder irrigation indicated; limiting instrumental ADL"",""Gross hematuria; transfusion, IV medications or hospitalization indicated; elective invasive intervention indicated; limiting self-care ADL"",""Life-threatening consequences; urgent invasive intervention indicated"",""Death""]}"
"Chronic kidney disease","{""src"":[{""pub"":""CTCAEv4.03"",""note"":""Modified"",""title"":""Renal and urinary disorders"",""section"":""Chronic kidney disease""},{""pub"":""http://www.kdigo.org/clinical_practice_guidelines/pdf/CKD/KDIGO_2012_CKD_GL.pdf"",""note"":""eGFR estimated used in the KDIGO estimating equations: ""}],""rubric"":[""eGFR (estimated Glomerular Filtration Rate) or CrCl (creatinine clearance) <LLN – 60 ml/min/1.73 m2 AND proteinuria 1+ present; urine protein/creatinine >0.5"",""eGFR or CrCl 59-30 ml/min/1.73 m2; medication (e.g., electrolytes, ACE inhibition, etc….) indicated or initiated"",""eGFR or CrCl 29-15 ml/min/1.73 m2"",""eGFR or CrCl <15 ml/min/1.73 m2; dialysis or renal transplant indicated or initiated/performed"",""Death""]}"
"Urinary tract calculi","{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Renal and urinary disorders"",""section"":""Renal calculi""}],""rubric"":[""Asymptomatic or mild symptoms; occasional use of nonprescription analgesics indicated"",""Symptomatic; oral antiemetics indicated; around the clock nonprescription analgesics or any oral narcotic analgesics indicated"",""Hospitalization indicated; IV intervention (e.g., analgesics, antiemetics); elective invasive intervention indicated"",""Life-threatening consequences; urgent invasive intervention indicated"",""Death""]}"
Osteonecrosis,"{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Musculoskeletal & connective tissue disorders"",""section"":""Avascular necrosis""}],""rubric"":[""Asymptomatic; clinical or diagnostic observations only; intervention not indicated"",""Symptomatic; medical intervention indicated (e.g., analgesics, anti-inflammatory); limiting instrumental ADL"",""Severe symptoms; limiting self-care ADL; elective operative intervention indicated"",""Life-threatening consequences; urgent intervention indicated"",""Death""]}"
"Slipped capital femoral epiphysis","{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Musculoskeletal & connective tissue disorders"",""section"":""Other, specify""}],""rubric"":[""Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated"",""Moderate; minimal, local or non-invasive intervention indicated; limiting age appropriate instrumental ADL"",""Severe or medically significant but not immediately life threatening; hospitalization or prolongation of existing hospitalization indicated; disabling; limiting self-care ADL"",""Life-threatening consequences; urgent intervention indicated"",""Death""]}"
Obesity,"{""src"":[{""pub"":""Centers for Disease Control and Prevention guidelines"",""note"":""New grading source for < 20 years""}],""rubric"":[""Not applicable"",""BMI 25 - 29.9 kg/m2"",""BMI 30 - 39.9 kg/m2"",""BMI >=40 kg/m2"",""Not applicable"",""Not applicable"",""BMI >= 85th%ile <95th%ile"",""BMI > 95th%ile"",""Not applicable"",""Not applicable""]}"
"Secondary Neoplasms","{""src"":[{""pub"":""Modified CTCAEv4.03"",""title"":""Neoplasms benign, malignant, and unspecified"",""section"":""Other, specified""}],""rubric"":[""Asymptomatic or mild symptoms; clinical or diagnostic observations only; low-grade neoplasms where intervention is not indicated [e.g. cervical intraepithelial neoplasia/cervical dysplasia/CIN, benign, asymptomatic meningioma and teratoma incidentally identified on imaging]"",""Moderate symptoms; minimal, local or noninvasive intervention indicated; limiting age appropriate instrumental ADL; low-grade, non-metastatic neoplasms [e.g. cervical carcinoma in-situ, cervical lymph node paraganglioma, basal cell carcinoma, squamous cell carcinoma, parotid carcinoma]"",""Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; disabling; limiting self-care ADL; high-grade neoplasms where single treatment therapy required (surgery, radiation or only one chemotherapeutic agent). [e.g. breast cancer if in-situ, prostate cancer, meningioma requiring intervention, bladder carcinoma, thyroid cancer, carcinoid, squamous cell carcinoma cervix, glioma, astrocytoma, gastrointestinal stromal tumor/GIST]"",""Life-threatening consequences; urgent intervention indicated; high-grade neoplasms where multimodal therapy required or more than one chemotherapy agent used [e.g. MDS, AML, ALL, Hodgkin lymphoma, non-Hodgkin lymphoma, non in-situ/ invasive breast cancer, osteosarcoma, Ewing sarcoma, primitive neuroectodermal tumor/ PNET, soft tissue sarcoma, renal cancer, anaplastic CNS tumor, glioblastoma, carcinoma of head/neck, liver cancer, lung cancer, mesothelioma, melanoma]"",""Death""]}"
Seizures,"{""src"":[{""pub"":""Multidisciplinary team consensus""}],""rubric"":[""Seizures not requiring medication"",""Seizures requiring one non-prn medication"",""Seizures requiring two or more non-prn medications; poorly controlled seizures with prescribed medications"",""Seizures requiring evaluation for surgical intervention"",""Death""]}"
"Severe headaches","{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Nervous system disorders"",""section"":""Headaches""}],""rubric"":[""Mild pain"",""Moderate pain requiring prescriptive abortive medication; limiting instrumental ADL"",""Severe pain requiring prophylactic medication; limiting self-care ADL"",""Not applicable"",""Not applicable""]}"
"Intervertebral disc disorder","{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Musculoskeletal & connective tissue disorders"",""section"":""Other, specify""}],""rubric"":[""Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated"",""Moderate; minimal, local or non-invasive intervention indicated; limiting age appropriate instrumental ADL"",""Severe or medically significant but not immediately life threatening; hospitalization or prolongation of existing hospitalization indicated; disabling; limiting self -care ADL"",""Life-threatening consequences; urgent intervention indicated"",""Death""]}"
Kyphosis,"{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Musculoskeletal & connective tissue disorders"",""section"":""Kyphosis""}],""rubric"":[""Not applicable"",""Moderate accentuation; limiting instrumental ADL"",""Severe accentuation; operative intervention indicated; limiting self-care ADL"",""Not applicable"",""Not applicable""]}"
Scoliosis,"{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Musculoskeletal & connective tissue disorders"",""section"":""Scoliosis""}],""rubric"":[""> 8 and <15 degrees; clinically undetectable"","">=15 - 30 degrees; visible by forward flexion; limiting instrumental ADL"","">=30 degrees; scapular prominence in forward flexion; operative intervention indicated; limiting self-care ADL; disabling"",""Not applicable"",""Not applicable""]}"
"Skeletal spine disorder","{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Musculoskeletal & connective tissue disorders"",""section"":""Other, specify""}],""rubric"":[""Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated"",""Moderate; minimal, local or non-invasive intervention indicated; limiting age appropriate instrumental ADL"",""Severe or medically significant but not immediately life threatening; hospitalization or prolongation of existing hospitalization indicated; disabling; limiting self-care ADL"",""Life-threatening consequences; urgent intervention indicated"",""Death""]}"
"Intracranial hemorrhage","{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Nervous system disorders"",""section"":""Intracranial hemorrhage""}],""rubric"":[""Asymptomatic; clinical or diagnostic observations only; intervention not indicated (MRI evidence of microhemorrhage, e.g. hemosiderin)"",""Moderate symptoms; medical intervention indicated"",""Ventriculostomy, ICP monitoring, intraventricular thrombolysis, or operative intervention indicated"",""Life-threatening consequences; urgent intervention indicated"",""Death""]}"
"Cerebrovascular accident","{""src"":[{""pub"":""CTCAE v4.03"",""title"":""Nervous system disorders"",""section"":""Stroke""}],""rubric"":[""Asymptomatic or mild neurologic deficit; radiographic findings only"",""Moderate neurologic deficit"",""Severe neurologic deficit"",""Life-threatening consequences; urgent intervention indicated"",""Death""]}"
"Cerebrovascular disease","{""src"":[{""pub"":""CTCAE v4.03"",""title"":""Nervous system disorders"",""section"":""Other, specify""}],""rubric"":[""Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated"",""Moderate; minimal, local or noninvasive intervention indicated; limiting age appropriate instrumental ADL"",""Severe or medically significant but not immediately life threatening; hospitalization or prolongation of existing hospitalization indicated; disabling; limiting self-care ADL"",""Life-threatening consequences; urgent intervention indicated"",""Death""]}"
"Heart valve disorder","{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Cardiac Disorders"",""section"":""Aortic valve disease; mitral valve disease; pulmonary valve disease; tricuspid valve disease""}],""rubric"":[""Asymptomatic valvular thickening/calcifications with or without mild valvular regurgitation or stenosis by imaging"",""Asymptomatic; moderate regurgitation or stenosis by imaging"",""Symptomatic; severe regurgitation or stenosis by imaging; symptoms controlled with medical intervention"",""Life-threatening consequences; urgent intervention indicated (e.g., valve replacement, valvuloplasty)"",""Death""]}"
Pericarditis,"{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Cardiac Disorders"",""section"":""Pericarditis""}],""rubric"":[""Asymptomatic, ECG or physical findings (e.g., rub) consistent with pericarditis"",""Symptomatic pericarditis (e.g., chest pain)"",""Pericarditis with physiologic consequences (e.g., pericardial constriction)"",""Life-threatening consequences; urgent intervention indicated (e.g., cardiac tamponade)"",""Death""]}"
"Aortic root aneurysm","{""src"":[{""pub"":""Modified CTCAE v4.03"",""title"":""Cardiac Disorders"",""section"":""Other, specify""}],""rubric"":[""Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated (aortic root >= 3.5 cm to < 4 cm)"",""Moderate; minimal, local or noninvasive intervention indicated; limiting age appropriate instrumental ADL (aortic root > = 4 cm)"",""Severe or medically significant but not immediately life threatening; hospitalization or prolongation of existing hospitalization indicated; disabling; limiting self-care ADL"",""Life-threatening consequences; urgent intervention indicated"",""Death""]}"
